Bals R. 2000. Epithelial antimicrobial peptides in host
defense against infections. Respiratory
Research 1, 141-150.
Braff M. H., Bardan A., Nizet V., Gallo R.L. 2005.
Cutaneous defense mechanisms by
antimicrobial peptides. Journal of
Investigative Dermotology 125, 9-13 .
Brodgen K.A. 2005. Antimicrobial peptides: pore
formes or metabolic inhibitors in bacteria.
Natura Reviews / Microbiology 3, 239-250.
Brogden K.A., Ackermann M., McCray P.B., Tack
B.F. 2003. Antimicrobial peptides in animals
and their role in host defences. International
Journal of Antimicrobial Agents 22, 465-478.
Heilborn J.D., Nilsson M.F., Kratz G., Weber G.,
Sorensen O., Borregaard N. 2003. The
cathelicidin anti-microbial peptide LL-37 is
involved in re-epithelialization of human skin
wounds and is lacking in chronic ulcer
epithelium. Journal of Investigative
Dermotology 120, 379-389.
Ho G., Broze G.J., Schwartz A. 1997. Role of
heparan sulfate proteoglycans in the uptake
and degradation of tissue factor pathway
inhibitor-coagulation factor Xa complexes. The
Journal of Biological Chemistry 27, 16838-16844.
Izadpanah A., Gallo R.L. 2005. Antimicrobial
Peptides. Journal of the American Academy of
Dermotology 52, 381-390.
Jongstra J., Schall T.J., Dyer B.J., Clayberger C.,
Jorgensen J., Davis M.M., 1987. The
isolation and sequence of a novel gene from a
human functional T cell line. The Journal of
Experimental Medicine 165, 601-614.
Kaspar A.A., Okada S., Kumar J., Poulain F.R.,
Drouvalakis K.A., Kelekar A. 2001. A
distinct pathway of cell-mediated apoptosis
initiated by granulysin. The Journal of
Immunology 167, 350-356.
S.
Koczulla R., Von Degenfeld G., Kupatt C., Krotz
F., Zahler S., Gloe T. 2003. An angiogenic
role for the human peptide antibiotic LL-37/hCAP-18. The Journal of Clinical
Investigation 111, 1665-1672.
Liu A.Y., Destoumieux D., Wong A.V., Park C.H.,
Valore E.V., Liu L. 2002. Human beta-defensin-2 production in keratinocytes is
regulated by interleukin-1, bacteria, and the
state of differentiation. Journal of Investigative
Dermotology 118, 275-281.
Ong P.Y., Ohtake T., Brandt C., Strickland I.,
Boguniewicz M., Ganz T. 2002. Endogenous
antimicrobial peptides and skin infections in
atopic dermatitis. The New England Journal of
Medicine 347, 1151-60.
Palffy R., Garglik R., Behuliak M., Kadasi L.,
Turna J., Celec P. 2009. On the physiology
and pathophysiology of antimicrobial peptides.
Molecular Medicine, 15 (1-2), 51-59
Peschel A., Jack R.W., Otto M., Collins L.V.,
Staubitz P., Nicholson G. 2001.
Staphylococcus aureus resistance to human
defensins and evasion of neutrophil killing via
the novel virulence factor MprF is based on
modification of membrane lipids with l-lysine.
The Journal of Experimental Medicine 193,
1067-1076.
Smet K.D., Contreras R. 2005. Human antimicrobial
peptides: defensins, cathelicidins and histatins.
Biotechnology Letters 47, 13337-13347.
Tzeng Y.L., Ambrose K.D., Zughaier S., Zhou X.,
Miller Y.K., Shafer W.M., Stephens D.S.
2005. Cationic antimicrobial peptide resistance
in Neissera meningitidis. Journal of
Bacteriology 187 (15), 5387-5396.
Valore E.V., Park C.H., Quayle A.J., Wiles K.R.,
McCray P.B.Jr., Ganz T. 1998. Human beta
defensin-1: an antimicrobial peptide of
urogenital tissues. The Journal of Clinical
Investigation 101, 1633-1642.
Wiliams A.J.F., Gallup J.M., Romero R.R.,
Brodgen K.A., Ackermann M.R. 2002.
Increasimg anionic peptide distribution and
intensity during progression and resolution of
bacterial pneumonia. Clinical and Diaonostic
Laboratory Immunology 9 (1), 28-32.
Zaiou M., Nizet V., Gallo R.L. 2003. Antimicrobial
and protease inhibitory functions of the human
cathelicidin (hCAP18/LL-37) prosequence.
Journal of Investigative Dermotology 120,
810-6.
Thank you for copying data from http://www.arastirmax.com
